Related Experiment Video
Updated: Jun 22, 2025

00:06
Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
Published on: August 20, 2019
15.1K
Endothelial Cell Dysfunction: Onset, Progression, and Consequences
Hojjat Naderi-Meshkin1, Wiwit Ananda Wahyu Setyaningsih1,2
1The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, BT9 7BL Belfast, UK.
Frontiers in Bioscience (Landmark Edition)
|June 28, 2024
Summary
Endothelial cell dysfunction arises from numerous factors, progressing through distinct stages with significant health consequences. Understanding this complex process is key to developing effective therapeutic strategies for cardiovascular diseases.
Area of Science:
- Cardiovascular Science
- Cell Biology
- Pathophysiology
Background:
- Endothelial cell dysfunction is a critical factor in cardiovascular diseases.
- It involves a complex interplay of causes, early/late events, and consequences.
Purpose of the Study:
- To provide a comprehensive overview of endothelial cell dysfunction.
- To outline therapeutic interventions targeting various stages of the dysfunction.
Main Methods:
- This review synthesizes existing literature on endothelial cell dysfunction.
- It examines causes, progression, consequences, and therapeutic strategies.
Main Results:
- Causes include hypertension, diabetes, smoking, obesity, inflammation, oxidative stress, and genetics.
- Early events involve activation and inflammation; late events include apoptosis and rarefaction.
- Consequences span remodelling, neovascularization, organ dysfunction, and clinical manifestations.
Conclusions:
- Endothelial cell dysfunction is a dynamic process influenced by multiple factors.
- Tailored therapeutic interventions are essential for mitigating its impact on health and cardiovascular disease progression.
Keywords:
blood vesselscardiovascular diseasesdisease modellingmetabolic disorderstherapeutic interventionsvascular dysfunctionMore Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis
5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K
Inflammation
53.3K
Overview
53.3K

